Janus-faced tumor microenvironment and redox

Antioxidants and Redox Signaling

Volumn 21, Issue 5, 2014, Pages 723-729

  Khramtsov, Valery V ^a,b   Gillies, Robert J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; CYSTEINYLGLYCINE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROXYL RADICAL; LIPID; METAL ION; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; ANTINEOPLASTIC AGENT;

ACIDOSIS; APOPTOSIS; CANCER CELL; CELL HYPOXIA; CELL PH; CELL PROLIFERATION; DISSOCIATION; EXTRACELLULAR MATRIX; FENTON REACTION; GENE OVEREXPRESSION; LIPID PEROXIDATION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; HOMEOSTASIS; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; GLUTATHIONE; HOMEOSTASIS; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; TUMOR MICROENVIRONMENT;

EID: 84899500056     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5864     Document Type: Review

References (74)

1. Backos DS, Franklin CC, and Reigan P. The role of glutathione in brain tumor drug resistance. Biochem Pharmacol 83: 1005-1012, 2012.
2. Bauer G. Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res 32: 2599-2624, 2012.
3. Bindra RS and Glazer PM. Genetic instability and the tumor microenvironment: towards the concept of microenvironmentinduced mutagenesis. Mutat Res 569: 75-85, 2005.
4. Bobko AA, Eubank TD, Voorhees JL, Efimova OV, Kirilyuk IA, Petryakov S, Trofimiov DG, Marsh CB, Zweier JL, Grigor'ev IA, Samouilov A, and Khramtsov VV. In vivo monitoring of pH, redox status, and glutathione using L-band EPR for assessment of therapeutic effectiveness in solid tumors. Magn Reson Med 67: 1827-1836, 2012.
5. Brahimi-Horn MC, Chiche J, and Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19: 223-229, 2007.
6. Bralet J, Schreiber L, and Bouvier C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem Pharmacol 43: 979-983, 1992.
7. Brurberg KG, Graff BA, and Rofstad EK. Temporal heterogeneity in oxygen tension in human melanoma xenografts. Br J Cancer 89: 350-356, 2003.
8. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.
9. Cadenas E and Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29: 222-230, 2000.
10. Chaiswing L and Oberley TD. Extracellular/microenvironmental redox state. Antioxid Redox Signal 13: 449-465, 2010.
11. Chen G, Chen Z, Hu Y, and Huang P. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by beta-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid Redox Signal 15: 2911-2921, 2011.
12. Corti A, Franzini M, Paolicchi A, and Pompella A. Gammaglutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res 30: 1169-1181, 2010.
13. Dautry-Varsat A, Ciechanover A, and Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A 80: 2258-2262, 1983.
14. de Bittencourt Junior PI, Curi R, and Williams JF. Glutathione metabolism and glutathione S-conjugate export ATPase (MRP1/GS-X pump) activity in cancer. I. Differential expression in human cancer cell lines. Biochem Mol Biol Int 45: 1227-1241, 1998.
15. Dhimitruka I, Bobko AA, Eubank TD, Komarov DA, and Khramtsov VV. Phosphonated trityl probe for concurrent in vivo tissue oxygen and pH monitoring using EPR-based techniques. JACS 135: 5904-5910, 2013.
16. di Ilio C, Sacchetta P, del Boccio G, la Rovere G, and Federici G. Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue. Cancer Lett 29: 37-42, 1985.
17. Dominici S, Paolicchi A, Corti A, Maellaro E, and Pompella A. Prooxidant reactions promoted by soluble and cell-bound gamma-glutamyltransferase activity. Methods Enzymol 401: 484-501, 2005.
18. Epe B. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice? Biol Chem 383: 467-475, 2002.
19. Erejuwa OO, Sulaiman SA, and Ab Wahab MS. Evidence in support of potential applications of lipid peroxidation products in cancer treatment. Oxid Med Cell Longev 2013: 931251, 2013.
20. Estrela JM, Ortega A, and Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181, 2006.
21. Franzini M, Corti A, Lorenzini E, Paolicchi A, Pompella A, De Cesare M, Perego P, Gatti L, Leone R, Apostoli P, and Zunino F. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer 42: 2623-2630, 2006.
22. Gee HE, Ivan C, Calin GA, and Ivan M. HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal 2013 [Epub ahead of print]; DOI: 10.1089/ars.2013.5639.
23. Gillies RJ and Gatenby RA. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr 39: 251-257, 2007.
24. Gillies RJ and Gatenby RA. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 26: 311-317, 2007.
25. Gillies RJ, Verduzco D, and Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 12: 487-493, 2012.
26. Grill HP, Zweier JL, Kuppusamy P, Weisfeldt ML, and Flaherty JT. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 20: 1604-1611, 1992.
27. Grimm C, Hofstetter G, Aust S, Mutz-Dehbalaie I, Bruch M, Heinze G, Rahhal-Schupp J, Reinthaller A, Concin N, and Polterauer S. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer 109: 610-614, 2013.
28. Hall AG. Review: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29: 238-245, 1999.
29. Hanigan MH. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst (e)ine. Carcinogenesis 16: 181-185, 1995.
30. Hanigan MH, Gallagher BC, Townsend DM, and Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 20: 553-559, 1999.
31. Hassan W, Ibrahim M, Nogueira CW, Ahmed M, and Rocha JB. Effects of acidosis and Fe (II) on lipid peroxidation in phospholipid extract: comparative effect of diphenyl diselenide and ebselen. Environ Toxicol Pharmacol 28: 152-154, 2009.
32. Haulica A and Ababei L. Comparative study of glycolytic activity in the erythrocytes of animals with chronic experimental hypoxia and with tumours. Neoplasma 21: 29-35, 1974.
33. Huang Z, Komninou D, Kleinman W, Pinto JT, Gilhooly EM, Calcagnotto A, and Richie JP, Jr. Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. Int J Cancer 120: 1396-1401, 2007.
34. Hutter DE, Till BG, and Greene JJ. Redox state changes in density-dependent regulation of proliferation. Exp Cell Res 232: 435-438, 1997.
35. Ibrahim-Hashim A, Cornnell HH, Abrahams D, Lloyd M, Bui M, Gillies RJ, and Gatenby RA. Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol 188: 624-631, 2012.
36. Ibrahim Hashim A, Cornnell HH, Coelho Ribeiro Mde L, Abrahams D, Cunningham J, Lloyd M, Martinez GV, Gatenby RA, and Gillies RJ. Reduction of metastasis using a non-volatile buffer. Clin Exp Metastasis 28: 841-849, 2011.
37. Ikebuchi Y, Masumoto N, Tasaka K, Koike K, Kasahara K, Miyake A, and Tanizawa O. Superoxide anion increases intracellular pH, intracellular free calcium, and arachidonate release in human amnion cells. J Biol Chem 266: 13233-13237, 1991.
38. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100: 1382-1388, 2009.
39. Kang YJ and Enger MD. Glutathione content and growth in A549 human lung carcinoma cells. Exp Cell Res 187: 177-179, 1990.
40. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202: 343-361, 1988.
41. Komarov DA, Dhimitruka I, Kirilyuk IA, Trofimiov DG, Grigor'ev IA, Zweier JL, and Khramtsov VV. Electron paramagnetic resonance monitoring of ischemia-induced myocardial oxygen depletion and acidosis in isolated rat hearts using soluble paramagnetic probes. Magn Reson Med 68: 649-655, 2012.
42. Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, and Mitchell JB. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62: 307-312, 2002.
43. Lauschke H, Tolba R, Burger B, Minor T, and Hirner A. Lipid peroxidation as additional marker in patients with colorectal cancer. Results of a preliminary study. Eur Surg Res 34: 346-350, 2002.
44. Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, and Wu TC. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Cancer Immunol Immunother 62: 1175-1185, 2013.
45. Leier I, Jedlitschky G, Buchholz U, Center M, Cole SP, Deeley RG, and Keppler D. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 314 (Pt 2): 433-437, 1996.
46. Liou GY and Storz P. Reactive oxygen species in cancer. Free Radic Res 44: 479-496, 2010.
47. Lipscomb DC, Gorman LG, Traystman RJ, and Hurn PD. Low molecular weight iron in cerebral ischemic acidosis in vivo. Stroke 29: 487-492; discussion 493, 1998.
48. Lora-Michiels M, Yu D, Sanders L, Poulson JM, Azuma C, Case B, Vujaskovic Z, Thrall DE, Charles HC, and Dewhirst MW. Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res 12: 5733-5740, 2006.
49. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L, and Chanvorachote P. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 285: 38832-38840, 2010.
50. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Knudsen ES, Sotgia F, and Lisanti MP. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9: 3256-3276, 2010.
51. Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, and Krishna MC. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res 12: 2455-2462, 2006.
52. Meijer TW, Kaanders JH, Span PN, and Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18: 5585-5594, 2012.
53. Mitchell JB, Biaglow JE, and Russo A. Role of glutathione and other endogenous thiols in radiation protection. Pharmacol Ther 39: 269-274, 1988.
54. Moyer MW. Targeting hypoxia brings breath of fresh air to cancer therapy. Nat Med 18: 636-637, 2012.
55. Oberley LW, Oberley TD, and Buettner GR. Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide. Med Hypotheses 7: 21-42, 1981.
56. Ortega A, Mena S, and Estrela JM. Glutathione in cancer cell death. Cancers 3: 1285-1310, 2011.
57. Policastro LL, Ibanez IL, Notcovich C, Duran HA, and Podhajcer OL. The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapy. Antioxid Redox Signal 19: 854-895, 2013.
58. Princiotto JV and Zapolski EJ. Difference between the two iron-binding sites of transferrin. Nature 255: 87-88, 1975.
59. Reynolds TY, Rockwell S, and Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 56: 5754-5757, 1996.
60. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, and Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 69: 2260-2268, 2009.
61. Robey IF and Martin NK. Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer. BMC Cancer 11: 235, 2011.
62. Roshchupkina GI, Bobko AA, Bratasz A, Reznikov VA, Kuppusamy P, and Khramtsov VV. In vivo EPR measurement of glutathione in tumor-bearing mice using improved disulfide biradical probe. Free Radic Biol Med 45: 312-320, 2008.
63. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
64. Siemann DW. (Ed). Tumor Microenvironment Chichester, UK; Hoboken, NJ: John Wiley & Sons, Ltd., 2011, p. 436.
65. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-295, 1997.
66. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, and Sullivan D. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82: 699-757, 2006.
67. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, Marinari UM, and Domenicotti C. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013: 972913, 2013.
68. Vishvakarma NK and Singh SM. Mechanisms of tumor growth retardation by modulation of pH regulation in the tumor-microenvironment of a murine T cell lymphoma. Biomed Pharmacother 65: 27-39, 2011.
69. Voegtlin C and Thompson JW. Glutathione content of tumor animals. J Biol Chem 70: 801-806, 1926.
70. Warburg O. On the origin of cancer cells. Science 123: 309-314, 1956.
71. Wilson WR and Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer 11: 393-410, 2011.
72. Wojtkowiak JW, Rothberg JM, Kumar V, Schramm KJ, Haller E, Proemsey JB, Lloyd MC, Sloane BF, and Gillies RJ. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72: 3938-3947, 2012.
73. Zhang HY, Hormi-Carver K, Zhang X, Spechler SJ, and Souza RF. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. Cancer Res 69: 9083-9089, 2009.
74. Zhu X, Zuo L, Cardounel AJ, Zweier JL, and He G. Characterization of in vivo tissue redox status, oxygenation, and formation of reactive oxygen species in postischemic myocardium. Antioxid Redox Signal 9: 447-455, 2007.